Curated News
By: NewsRamp Editorial Staff
October 12, 2026
Apimeds' MindWave Signs Three Blockchain Network Deals
TLDR
- MindWave's three blockchain contracts offer 20% token allocations plus recurring fees, positioning APUS for potential revenue growth.
- MindWave will build dedicated blockchain networks on MindChain for climate, sports, and insurance clients, earning fees or equity.
- MindWave's blockchain networks aim to improve transparency in environmental credits, ticketing, and insurance for a better tomorrow.
- MindWave signed three blockchain deals in late 2026 for climate, sports, and insurance, each granting 20% token allocations.
Impact - Why it Matters
This news matters because it demonstrates MindWave's ability to commercialize its MindChain infrastructure across diverse industries, potentially generating recurring revenue streams from token allocations and service fees. For Apimeds, these agreements could provide a path toward financial stability, though the going concern warning underscores the risks. Investors should monitor the execution of these networks, as success could validate the blockchain-as-a-service model and drive adoption in climate finance, sports media, and insurance. The deals also signal growing demand for dedicated blockchain solutions in traditional sectors.
Summary
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc. USA, signed three agreements between Sept. 24 and Oct. 4, 2026, to build and operate dedicated blockchain networks on its MindChain infrastructure. The clients span climate finance, sports media, and insurance: Singapore-based AQUAE Holdings for its AQUAEChain environmental credit platform, New York-based Flash Sports & Media Holdings for its FlashChain digital ticketing and media authentication network, and Delaware-based BlockAssure for its AssureChain insurance and reinsurance network. Under the agreements, MindWave will receive contracted fees or equity along with allocations equal to 20% of the applicable credits or tokens, creating opportunities for recurring revenue as the networks become operational.
Separately, Apimeds reiterated that its audited consolidated financial statements for 2025 included an explanatory paragraph from its independent auditor expressing substantial doubt about its ability to continue as a going concern. The disclosure was made pursuant to NYSE American requirements and does not amend the company’s previous filings. For full details, visit https://ibn.fm/UPsNX. The company’s latest news and updates are available in its newsroom at https://ibn.fm/APUS.
MindWave Innovations, a wholly owned subsidiary of Apimeds, develops technology infrastructure and digital solutions for blockchain-enabled applications, data-driven platforms, and emerging commercial ecosystems. Its MindChain blockchain infrastructure supports transparent, traceable, and verifiable digital transactions, designed for digital assets, registries, tokenized ecosystems, and decentralized services. Through projects such as AssureChain, MindWave is expanding into insurance, reinsurance, and digital-asset-enabled insurance models. The announcement was distributed via MissionIR, a specialized communications platform within the Dynamic Brand Portfolio @ IBN, which provides wire solutions, syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Apimeds' MindWave Signs Three Blockchain Network Deals
